Drug Shortage Report for ATROPINE SULFATE INJECTION USP

Last updated on 2020-03-10 History
Report ID 63646
Drug Identification Number 00328154
Brand name ATROPINE SULFATE INJECTION USP
Common or Proper name Atropine Sulfate Injection USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 0.1MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 x 5mL LifeShield
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-12-21
Estimated end date
Actual end date 2020-03-09
Shortage status Resolved
Updated date 2020-03-10
Company comments
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v35 2020-03-10 French Compare
v34 2020-03-10 English Compare
v33 2020-02-19 French Compare
v32 2020-02-19 English Compare
v31 2020-01-15 French Compare
v30 2020-01-15 English Compare
v29 2019-12-04 French Compare
v28 2019-12-04 English Compare
v27 2019-12-04 French Compare
v26 2019-12-04 English Compare
v25 2019-12-04 French Compare
v24 2019-12-04 English Compare
v23 2019-09-04 French Compare
v22 2019-09-04 English Compare
v21 2019-06-12 French Compare
v20 2019-06-12 English Compare
v19 2019-02-26 French Compare
v18 2019-02-26 English Compare
v17 2019-01-16 French Compare
v16 2019-01-16 English Compare

Showing 1 to 20 of 35